Concierge and direct primary care models charge patients an annual or monthly membership fee for more personalised primary care. Concierge practices keep billing insurance for visits and procedures, while direct primary care usually operates outside the insurance system.
Researchers from Johns Hopkins Carey Business School, the Johns Hopkins Bloomberg School of Public Health, Oregon Health & Science University, and Harvard Medical School reported their findings in Health Affairs. They analysed a national sample of more than 6,000 practices from 2018 to 2023. In that period, practice sites rose from 1,658 to 3,036 and clinicians increased from 3,935 to 7,021.
The team found clinicians are moving into these models partly because they often have smaller patient panels, less administrative burden, and greater autonomy, which can reduce burnout. The study also notes a large rise in corporate-affiliated practices and recommends policymakers monitor these trends to protect broad access to primary care.
Difficult words
- concierge — a primary care practice with extra paid services
- direct primary care — primary medical care outside the insurance system
- membership — a regular payment to belong to a service
- clinician — a healthcare professional who provides medical careclinicians
- patient panel — the group of patients a clinician cares forpatient panels
- administrative burden — extra work from paperwork and insurance rules
- autonomy — freedom to make professional decisions at work
- policymaker — a person who makes public health or policy decisionspolicymakers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you consider paying a membership fee for more personalised primary care? Why or why not?
- How might smaller patient panels and greater clinician autonomy affect quality of care?
- What could policymakers do locally to protect broad access to primary care as these models grow?
Related articles
PAHO issues first guide for tungiasis treatment
PAHO has published the first evidence-based guide to treat tungiasis, recommending low-viscosity dimethicone and warning against unsafe manual removal. The disease affects millions in Latin America, the Caribbean and Sub-Saharan Africa.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
